Studying 107 adults aged 26 to 86, researchers found that aging muscles increasingly tense against each other around the ankle — a “safety-first” stiffening that saps push-off power.
The Raleigh biotech priced its Nasdaq debut at $13 a share to fund mizagliflozin, an oral drug aimed at the dangerous blood-sugar crashes some patients face after bariatric surgery.
A study of 402 adults found that physical activity and controlled blood sugar in midlife were associated with better preserved thinking skills decades later.
Dutch researchers found that low-dose digoxin — a drug derived from foxglove and costing pennies a day — reduced heart-failure hospitalizations by about 25% in a large placebo-controlled trial.
In a six-year study of older adults, having both abdominal obesity and low vitamin D was tied to more than double the risk of death — each condition amplifying the other.
Analyzing 20 years of U.S. health data, researchers found blood bicarbonate has crept up as CO2 climbed — a correlation they say warrants monitoring, not alarm.
In mice, an appetite-neuron protein called OPA1 guarded against overeating fat and obesity — and its loss hit females harder, hinting at more personalized obesity treatment.
Princeton researchers found that when fiber runs low, gut bacteria break down the intestine’s protective mucus — producing harmful byproducts linked to worse outcomes in disease.
The Venrock-led round backs a platform that lets self-funded employers contract, in one deal, with thousands of advanced primary-care practices that sit outside insurance networks.
The partnership will use quantum algorithms to design better photosensitizers — molecules that kill tumor cells when hit with light — a task classical computers struggle with.
Adding BioLife’s cell-preservation technology to its bioprocessing tools, Repligen is betting on vertical integration as cell and gene therapies scale up.
Whitehead Institute scientists found polyamines act as ‘storage lockers’ for iron — and draining them could poison cancer cells with their own iron.